Trial registry

A public database where studies are recorded before they start, so anyone can see what is being tested and check results are reported. ISRCTN and ClinicalTrials.gov are examples.

Also called: isrctn, clinicaltrials.gov, clinical trials register, trial register, nct number

Related words randomised controlled trial

Topics Research

Questions people ask

How can I take part in a Crohn's clinical trial?

The NHS suggests asking your doctor or a patient organisation about trials you may be eligible for. You can also search the NIHR's Be Part of Research website for UK studies and contact research teams directly. Registries such as ISRCTN and ClinicalTrials.gov list studies and their results. Crohn's & Colitis UK explains how new medicines are tested before they are licensed.

Sources

Where to read more

ISRCTN Registry

ISRCTN Tool Patients and professionals

A WHO-recognised registry where UK and international studies are recorded before they start, with their aims and progress. You can search it free for Crohn's studies, including UK trials such as PROFILE. Records are written for researchers, so they can be technical.

Topics Research

Jargon explained trial registry study protocol ISRCTN number

Dietary interventions for induction and maintenance of remission in inflammatory bowel disease

Cochrane Systematic review Feb 2019 Patients and professionals

Reviewed trials of special diets (such as low-sugar, low-red-meat or exclusion diets) for Crohn's and colitis. The effects were uncertain and no firm conclusions could be drawn. The authors say experts need to agree what the diets should contain and more trials are needed.

Topics Diet and nutrition

Jargon explained dietary intervention randomised controlled trial

Diets for inducing and maintaining remission in inflammatory bowel disease (IBD)

Cochrane Systematic review Feb 2019 Patients and professionals

A Cochrane review of 18 trials that tested cutting down or cutting out foods thought to provoke IBD symptoms. The authors found the evidence too weak to say whether any of these diets help bring on or keep remission, and called for better trials. This summary dates from 2019.

Topics Diet and nutrition Research

Jargon explained remission exclusion diet randomised controlled trial

Infliximab, azathioprine, or combination therapy for Crohn's disease (SONIC)

New England Journal of Medicine Study Apr 2010 Patients and professionals

A landmark trial of 508 adults with moderate to severe Crohn's who had never had immunosuppressants or biologics. Infliximab and azathioprine together worked best: about 57% were in remission without steroids at 26 weeks, against 44% on infliximab alone and 30% on azathioprine alone. This is why many people starting infliximab are offered a second 'helper' drug alongside it.

Topics Biologics and newer medicines Immunosuppressants Research

Jargon explained combination therapy steroid-free remission mucosal healing randomised controlled trial

Crohn's Disease Exclusion Diet Plus Partial Enteral Nutrition Induces Sustained Remission in a Randomized Controlled Trial

Gastroenterology Study Aug 2019 Patients and professionals

A trial in 78 children with mild to moderate Crohn's. The Crohn's Disease Exclusion Diet (CDED) plus half their calories from a special drink was much easier to stick to than a liquid-only diet (EEN). Both worked well at 6 weeks, but by 12 weeks more children on CDED were still in remission (76% against 45%). It made CDED a recognised option for children.

Topics Diet and nutrition Children and young people

Jargon explained Crohn's disease exclusion diet partial enteral nutrition exclusive enteral nutrition microbiome

A biomarker-stratified comparison of top-down versus accelerated step-up treatment strategies for patients with newly diagnosed Crohn's disease (PROFILE)

The Lancet Gastroenterology & Hepatology Study May 2024 Patients and professionals

A large UK-led trial of 386 newly diagnosed adults. Starting straight away with infliximab plus an immunosuppressant ('top-down') kept 79% in remission without steroids or surgery for a year, compared with 15% using the usual 'step-up' approach of trying milder drugs first. There were also fewer flares, serious side effects and operations. A blood test meant to predict who needed strong treatment did not help. Free to read in full.

Topics Biologics and newer medicines Research About Crohn's disease

Jargon explained top-down treatment step-up treatment biomarker steroid-free remission top-down step-up immunomodulator randomised controlled trial

Crohn's disease management after intestinal resection: a randomised trial (POCER)

The Lancet Study Feb 2015 For professionals

A trial of how to stop Crohn's returning after bowel surgery. Treating people according to their risk, checking with a colonoscopy at six months and stepping up treatment if the disease had come back worked better than standard drug treatment alone. It also showed that even low-risk patients need monitoring.

Topics Surgery Monitoring Research

Jargon explained post-operative recurrence colonoscopy step-up resection

Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial

The Lancet Study May 2002 Patients and professionals

This trial asked whether people who improve after a first dose of infliximab should keep having it. Those given regular doses every 8 weeks were more likely to be in remission at 30 and 54 weeks, more likely to come off steroids, and stayed well for longer than those who stopped. Serious infections were no more common. It set the pattern of regular, ongoing infliximab treatment.

Topics Biologics and newer medicines Research

Jargon explained maintenance therapy remission placebo

National IBD Registry

National IBD Registry Data Patients and professionals

The UK registry that collects health data from people with IBD to help improve care and support research. It has been running since 2012 and joined NHS England in 2026. Hospital teams use it to compare their services, and people with IBD can find out what data is collected about them.

Topics Research Monitoring

Jargon explained registry quality improvement

Effect of tight control management on Crohn's disease (CALM): a multicentre, randomised, controlled phase 3 trial

The Lancet Study Dec 2017 Patients and professionals

CALM compared deciding treatment on symptoms alone with 'tight control', where treatment was stepped up if blood or poo tests (CRP and faecal calprotectin) showed inflammation even when people felt fine. After 48 weeks, 46% in the tight control group had a healed bowel lining compared with 30% in the symptom-only group. It is a cornerstone of the 'treat to target' approach.

Topics Monitoring Biologics and newer medicines Research

Jargon explained tight control faecal calprotectin CRP mucosal healing treat to target

Clinical trials

NHS Web page Dec 2022 For patients

The NHS explains what a clinical trial is and how to find one. It suggests asking your doctor or a patient organisation, and points to the Be Part of Research website, where you can search UK studies and contact researchers.

Topics Research

Jargon explained clinical trial randomised

Search everything for "trial registry"